HOU Yanyan 1,2,3,4 , ZHU Beibei 1,2,3,4 , LU Mengjuan 1,2,3,4 , JIANG Minmin 2,3,5 , YU Xiayan 1,2,3,4 , GU Yue 1,2,3,4 , LI Haiyan 1,2,3,4 , TAO Fangbiao 1,2,3,4
  • 1. Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Hefei 230032, P. R. China;
  • 2. Key Laboratory of Population Health Across Life Cycle, Ministry of Education, Hefei 230032, P. R. China;
  • 3. Anhui Provincial Key Laboratory of Population Health and Aristogenics, Hefei 230032, P. R. China;
  • 4. Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, National Health Commission, Hefei 230032, P. R. China;
  • 5. Department of Occupational Health and Environmental Health, Anhui Medical University, Hefei 230032, P. R. China;
TAO Fangbiao, Email: fbtao@ahmu.edu.cn
Export PDF Favorites Scan Get Citation

Objective  To preliminarily assess the ameliorative effect of Mom’s Good Mood (MGM) on the prevalence of antenatal depression based on a pilot study, and to provide evidence for a scale-up study. Methods  This study was conducted in Ma’anshan Maternal and Child Health Center as a pilot study of an implementation study conducted in China called the Perinatal Depression Screening and Management (PDSM) program. In 2019, 1 189 participants (gestational week ≤14+6 weeks) were included in the implementation group. Females were recruited in the first trimester and followed up in the second and third trimesters. At each time point, the participants’ depression status was screened by the Edinburgh postpartum depression scale (EPDS), and those who were screened as having depression were provided the MGM intervention. In 2020, 1 708 participants who underwent screening with the EPDS in either the first, second or third trimester at Ma’anshan Maternal and Child Health Center were included in the control group. Mann‒Whitney U test, Chi-square, and multivariate logistic regression analysis were used to compare the EPDS scores and depression prevalence between the control and implementation groups to assess the ameliorative effect of MGM (screening and intervention) on antenatal depression. Results  In the first trimester, there were no statistically significant differences in EPDS scores or depression prevalence between the two groups (P>0.05). In the second and third trimesters, both the EPDS scores and depression prevalence of the implementation group were lower than those of the control group (P<0.05). After adjusting for confounders, logistic regression analysis showed that the risks of depression in the implementation group in both the second and third trimesters were lower than those in the control group (ORsecond trimester=0.55, 95%CI 0.37 to 0.81, P=0.003; ORthird trimester=0.51, 95%CI 0.35 to 0.74, P<0.001). Conclusion  Implementation of the MGM based on the primary care system can effectively reduce the prevalence of antenatal depression, providing evidence for further scale up.

Citation: HOU Yanyan, ZHU Beibei, LU Mengjuan, JIANG Minmin, YU Xiayan, GU Yue, LI Haiyan, TAO Fangbiao. A pilot study on the ameliorative effect of "Mom’s Good Mood" on antenatal depression. Chinese Journal of Evidence-Based Medicine, 2022, 22(9): 1012-1019. doi: 10.7507/1672-2531.202204129 Copy

  • Previous Article

    Cost minimization analysis of Danmu extract syrup and Xiaoer Chiqiao Qingre granules for acute upper respiratory tract infection in children
  • Next Article

    Efficacy and safety of orlistat in the treatment of overweight and obese type 2 diabetes mellitus: a meta-analysis